These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32662850)
1. Use of Run-in Periods in Randomized Trials. Huo X; Armitage J JAMA; 2020 Jul; 324(2):188-189. PubMed ID: 32662850 [No Abstract] [Full Text] [Related]
5. The design and use of cluster randomised controlled trials in evaluating injury prevention interventions: part 1. Rationale, design and informed consent. DiGuiseppi C; Coupland C Inj Prev; 2010 Feb; 16(1):61-7. PubMed ID: 20179039 [No Abstract] [Full Text] [Related]
6. Enhancing adherence in randomized controlled clinical trials. Shumaker SA; Dugan E; Bowen DJ Control Clin Trials; 2000 Oct; 21(5 Suppl):226S-32S. PubMed ID: 11018580 [TBL] [Abstract][Full Text] [Related]
7. Randomize, then consent: a strategy for improving patient acceptance of participation in randomized controlled trials. Lubowitz JH Arthroscopy; 2006 Sep; 22(9):1007-8. PubMed ID: 16958184 [TBL] [Abstract][Full Text] [Related]
8. Understanding and evaluating clinical trials. Bigby M; Gadenne AS J Am Acad Dermatol; 1996 Apr; 34(4):555-90; quiz 591-3. PubMed ID: 8601646 [TBL] [Abstract][Full Text] [Related]
9. Research ethics and clinical trials: fostering collaboration with research participants. Phipps E; Fleetwood J; Piraino A Account Res; 1999; 6(3):215-26. PubMed ID: 11658125 [No Abstract] [Full Text] [Related]
10. Historical controls, data banks, and randomized trials in clinical research: a review. Fleming TR Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214 [No Abstract] [Full Text] [Related]
11. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. Avins AL J Med Ethics; 1998 Dec; 24(6):401-8. PubMed ID: 9873981 [TBL] [Abstract][Full Text] [Related]
12. A research agenda for understanding participation in clinical research. Gross D Res Nurs Health; 2006 Jun; 29(3):172-5. PubMed ID: 16676344 [No Abstract] [Full Text] [Related]
13. Ethical considerations concerning treatment allocation in drug development trials. Senn S Stat Methods Med Res; 2002 Oct; 11(5):403-11. PubMed ID: 12357586 [TBL] [Abstract][Full Text] [Related]
14. Informed consent after randomization. Papaioannau A Lancet; 1982 Oct; 2(8302):828. PubMed ID: 6126702 [No Abstract] [Full Text] [Related]
15. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
16. Strategy and alternate randomized designs in cancer clinical trials. Zelen M Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213 [No Abstract] [Full Text] [Related]